Endpoints News ٣ مارس ٢٠٢٦ Moderna will pay $950M to settle Covid vaccine patent claims with Arbutus, Roivant
Endpoints News ٢٥ فبراير ٢٠٢٦ Polymer nanoparticle startup BreezeBio raises $60M for mRNA diabetes therapy
Endpoints News ٢١ فبراير ٢٠٢٦ Potential Eylea competitor disappoints; FDA to review Moderna’s flu vaccine; Another rare disease rejection; and more
Endpoints News ١٨ فبراير ٢٠٢٦ Reversal on Moderna's flu application follows atypical path through FDA
Endpoints News ١١ فبراير ٢٠٢٦ Prasad overruled vaccine review team, office director on Moderna flu shot
Endpoints News ١٠ فبراير ٢٠٢٦ Moderna accuses FDA of shifting standard as agency refuses flu shot review
Endpoints News ٢١ نوفمبر ٢٠٢٥ Sarepta ends Elevidys trial with Hansa's pre-treatment; Some pipeline cuts at Moderna #Blue Lake #Inhibikase Therapeutics